Sharing data and a collaborative relationship are 2 best practices from commercial payers participating in the Oncology Care Model, according to Ron Kline, MD, FAAP, of the Center for Medicare and Medicaid Innovation.
Sharing data and a collaborative relationship are 2 best practices from commercial payers participating in the Oncology Care Model, according to Ron Kline, MD, FAAP, of the Center for Medicare and Medicaid Innovation.
Transcript
What is the emerging experience with Oncology Care Models (OCM) for commercial payers?
Well, we have 14 commercial payers that are a part of OCM. They follow basic guidelines, which is a care management fee and a value-based payment system. I think they are learning in their interactions with practices. You heard people say this morning that really making it more of a collaborative relationship rather than a conflict relationship is better. I think that practices have discovered, the commercial payers have discovered, that sharing data with our practices is very important because if you don’t have information you can’t improve your practice. I think that is what’s occurring and I think their experience with OCM or OCM-like programs have been positive.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More